Report Detail

Pharma & Healthcare Global Fibroblast Growth Factor Receptor 2 Sales Market Report 2018

  • RnM1571770
  • |
  • 22 June, 2018
  • |
  • Global
  • |
  • 124 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Global Fibroblast Growth Factor Receptor 2 Sales Market Report 2018

      1 Fibroblast Growth Factor Receptor 2 Market Overview

      • 1.1 Product Overview and Scope of Fibroblast Growth Factor Receptor 2
      • 1.2 Classification of Fibroblast Growth Factor Receptor 2 by Product Category
        • 1.2.1 Global Fibroblast Growth Factor Receptor 2 Market Size (Sales) Comparison by Type (2013-2025)
        • 1.2.2 Global Fibroblast Growth Factor Receptor 2 Market Size (Sales) Market Share by Type (Product Category) in 2017
        • 1.2.3 ASP-5878
        • 1.2.4 AZD-4547
        • 1.2.5 BAY-1163877
        • 1.2.6 CPL-043
        • 1.2.7 Debio-1347
        • 1.2.8 EDP-317
        • 1.2.9 Others
      • 1.3 Global Fibroblast Growth Factor Receptor 2 Market by Application/End Users
        • 1.3.1 Global Fibroblast Growth Factor Receptor 2 Sales (Volume) and Market Share Comparison by Application (2013-2025)
        • 1.3.1 Clinic
        • 1.3.2 Hospital
        • 1.3.3 Others
      • 1.4 Global Fibroblast Growth Factor Receptor 2 Market by Region
        • 1.4.1 Global Fibroblast Growth Factor Receptor 2 Market Size (Value) Comparison by Region (2013-2025)
        • 1.4.2 United States Fibroblast Growth Factor Receptor 2 Status and Prospect (2013-2025)
        • 1.4.3 Europe Fibroblast Growth Factor Receptor 2 Status and Prospect (2013-2025)
        • 1.4.4 China Fibroblast Growth Factor Receptor 2 Status and Prospect (2013-2025)
        • 1.4.5 Japan Fibroblast Growth Factor Receptor 2 Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Fibroblast Growth Factor Receptor 2 Status and Prospect (2013-2025)
        • 1.4.7 India Fibroblast Growth Factor Receptor 2 Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value and Volume) of Fibroblast Growth Factor Receptor 2 (2013-2025)
        • 1.5.1 Global Fibroblast Growth Factor Receptor 2 Sales and Growth Rate (2013-2025)
        • 1.5.2 Global Fibroblast Growth Factor Receptor 2 Revenue and Growth Rate (2013-2025)

      2 Global Fibroblast Growth Factor Receptor 2 Competition by Players/Suppliers, Type and Application

      • 2.1 Global Fibroblast Growth Factor Receptor 2 Market Competition by Players/Suppliers
        • 2.1.1 Global Fibroblast Growth Factor Receptor 2 Sales and Market Share of Key Players/Suppliers (2013-2018)
        • 2.1.2 Global Fibroblast Growth Factor Receptor 2 Revenue and Share by Players/Suppliers (2013-2018)
      • 2.2 Global Fibroblast Growth Factor Receptor 2 (Volume and Value) by Type
        • 2.2.1 Global Fibroblast Growth Factor Receptor 2 Sales and Market Share by Type (2013-2018)
        • 2.2.2 Global Fibroblast Growth Factor Receptor 2 Revenue and Market Share by Type (2013-2018)
      • 2.3 Global Fibroblast Growth Factor Receptor 2 (Volume and Value) by Region
        • 2.3.1 Global Fibroblast Growth Factor Receptor 2 Sales and Market Share by Region (2013-2018)
        • 2.3.2 Global Fibroblast Growth Factor Receptor 2 Revenue and Market Share by Region (2013-2018)
      • 2.4 Global Fibroblast Growth Factor Receptor 2 (Volume) by Application

      3 United States Fibroblast Growth Factor Receptor 2 (Volume, Value and Sales Price)

      • 3.1 United States Fibroblast Growth Factor Receptor 2 Sales and Value (2013-2018)
        • 3.1.1 United States Fibroblast Growth Factor Receptor 2 Sales and Growth Rate (2013-2018)
        • 3.1.2 United States Fibroblast Growth Factor Receptor 2 Revenue and Growth Rate (2013-2018)
        • 3.1.3 United States Fibroblast Growth Factor Receptor 2 Sales Price Trend (2013-2018)
      • 3.2 United States Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Players (2013-2018)
      • 3.3 United States Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Type (2013-2018)
      • 3.4 United States Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Application (2013-2018)

      4 Europe Fibroblast Growth Factor Receptor 2 (Volume, Value and Sales Price)

      • 4.1 Europe Fibroblast Growth Factor Receptor 2 Sales and Value (2013-2018)
        • 4.1.1 Europe Fibroblast Growth Factor Receptor 2 Sales and Growth Rate (2013-2018)
        • 4.1.2 Europe Fibroblast Growth Factor Receptor 2 Revenue and Growth Rate (2013-2018)
        • 4.1.3 Europe Fibroblast Growth Factor Receptor 2 Sales Price Trend (2013-2018)
      • 4.2 Europe Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Players (2013-2018)
      • 4.3 Europe Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Type (2013-2018)
      • 4.4 Europe Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Application (2013-2018)

      5 China Fibroblast Growth Factor Receptor 2 (Volume, Value and Sales Price)

      • 5.1 China Fibroblast Growth Factor Receptor 2 Sales and Value (2013-2018)
        • 5.1.1 China Fibroblast Growth Factor Receptor 2 Sales and Growth Rate (2013-2018)
        • 5.1.2 China Fibroblast Growth Factor Receptor 2 Revenue and Growth Rate (2013-2018)
        • 5.1.3 China Fibroblast Growth Factor Receptor 2 Sales Price Trend (2013-2018)
      • 5.2 China Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Players (2013-2018)
      • 5.3 China Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Type (2013-2018)
      • 5.4 China Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Application (2013-2018)

      6 Japan Fibroblast Growth Factor Receptor 2 (Volume, Value and Sales Price)

      • 6.1 Japan Fibroblast Growth Factor Receptor 2 Sales and Value (2013-2018)
        • 6.1.1 Japan Fibroblast Growth Factor Receptor 2 Sales and Growth Rate (2013-2018)
        • 6.1.2 Japan Fibroblast Growth Factor Receptor 2 Revenue and Growth Rate (2013-2018)
        • 6.1.3 Japan Fibroblast Growth Factor Receptor 2 Sales Price Trend (2013-2018)
      • 6.2 Japan Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Players (2013-2018)
      • 6.3 Japan Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Type (2013-2018)
      • 6.4 Japan Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Application (2013-2018)

      7 Southeast Asia Fibroblast Growth Factor Receptor 2 (Volume, Value and Sales Price)

      • 7.1 Southeast Asia Fibroblast Growth Factor Receptor 2 Sales and Value (2013-2018)
        • 7.1.1 Southeast Asia Fibroblast Growth Factor Receptor 2 Sales and Growth Rate (2013-2018)
        • 7.1.2 Southeast Asia Fibroblast Growth Factor Receptor 2 Revenue and Growth Rate (2013-2018)
        • 7.1.3 Southeast Asia Fibroblast Growth Factor Receptor 2 Sales Price Trend (2013-2018)
      • 7.2 Southeast Asia Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Players (2013-2018)
      • 7.3 Southeast Asia Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Type (2013-2018)
      • 7.4 Southeast Asia Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Application (2013-2018)

      8 India Fibroblast Growth Factor Receptor 2 (Volume, Value and Sales Price)

      • 8.1 India Fibroblast Growth Factor Receptor 2 Sales and Value (2013-2018)
        • 8.1.1 India Fibroblast Growth Factor Receptor 2 Sales and Growth Rate (2013-2018)
        • 8.1.2 India Fibroblast Growth Factor Receptor 2 Revenue and Growth Rate (2013-2018)
        • 8.1.3 India Fibroblast Growth Factor Receptor 2 Sales Price Trend (2013-2018)
      • 8.2 India Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Players (2013-2018)
      • 8.3 India Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Type (2013-2018)
      • 8.4 India Fibroblast Growth Factor Receptor 2 Sales Volume and Market Share by Application (2013-2018)

      9 Global Fibroblast Growth Factor Receptor 2 Players/Suppliers Profiles and Sales Data

      • 9.1 Advenchen Laboratories, LLC
        • 9.1.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.1.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.1.2.1 Product A
          • 9.1.2.2 Product B
        • 9.1.3 Advenchen Laboratories, LLC Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.1.4 Main Business/Business Overview
      • 9.2 Amgen Inc.
        • 9.2.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.2.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.2.2.1 Product A
          • 9.2.2.2 Product B
        • 9.2.3 Amgen Inc. Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.2.4 Main Business/Business Overview
      • 9.3 ArQule, Inc.
        • 9.3.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.3.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.3.2.1 Product A
          • 9.3.2.2 Product B
        • 9.3.3 ArQule, Inc. Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.3.4 Main Business/Business Overview
      • 9.4 Astellas Pharma Inc.
        • 9.4.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.4.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.4.2.1 Product A
          • 9.4.2.2 Product B
        • 9.4.3 Astellas Pharma Inc. Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.4.4 Main Business/Business Overview
      • 9.5 AstraZeneca Plc
        • 9.5.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.5.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.5.2.1 Product A
          • 9.5.2.2 Product B
        • 9.5.3 AstraZeneca Plc Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.5.4 Main Business/Business Overview
      • 9.6 AVEO Pharmaceuticals, Inc.
        • 9.6.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.6.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.6.2.1 Product A
          • 9.6.2.2 Product B
        • 9.6.3 AVEO Pharmaceuticals, Inc. Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.6.4 Main Business/Business Overview
      • 9.7 Batu Biologics, Inc.
        • 9.7.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.7.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.7.2.1 Product A
          • 9.7.2.2 Product B
        • 9.7.3 Batu Biologics, Inc. Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.7.4 Main Business/Business Overview
      • 9.8 Bayer AG
        • 9.8.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.8.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.8.2.1 Product A
          • 9.8.2.2 Product B
        • 9.8.3 Bayer AG Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.8.4 Main Business/Business Overview
      • 9.9 Boehringer Ingelheim GmbH
        • 9.9.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.9.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.9.2.1 Product A
          • 9.9.2.2 Product B
        • 9.9.3 Boehringer Ingelheim GmbH Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.9.4 Main Business/Business Overview
      • 9.10 Bristol-Myers Squibb Company
        • 9.10.1 Company Basic Information, Manufacturing Base and Competitors
        • 9.10.2 Fibroblast Growth Factor Receptor 2 Product Category, Application and Specification
          • 9.10.2.1 Product A
          • 9.10.2.2 Product B
        • 9.10.3 Bristol-Myers Squibb Company Fibroblast Growth Factor Receptor 2 Sales, Revenue, Price and Gross Margin (2013-2018)
        • 9.10.4 Main Business/Business Overview
      • 9.11 Celon Pharma Sp. z o.o.
      • 9.12 Debiopharm International SA
      • 9.13 Eddingpharm
      • 9.14 Eisai
      • 9.15 Eli Lilly and Company
      • 9.16 Hutchison MediPharma Limited
      • 9.17 Incyte Corporation
      • 9.18 Johnson & Johnson
      • 9.19 Les Laboratoires Servier SAS
      • 9.20 Nobelpharma Co., Ltd.
      • 9.21 Novartis AG
      • 9.22 Principia Biopharma Inc.
      • 9.23 Vichem Chemie Research Ltd.

      10 Fibroblast Growth Factor Receptor 2 Maufacturing Cost Analysis

      • 10.1 Fibroblast Growth Factor Receptor 2 Key Raw Materials Analysis
        • 10.1.1 Key Raw Materials
        • 10.1.2 Price Trend of Key Raw Materials
        • 10.1.3 Key Suppliers of Raw Materials
        • 10.1.4 Market Concentration Rate of Raw Materials
      • 10.2 Proportion of Manufacturing Cost Structure
        • 10.2.1 Raw Materials
        • 10.2.2 Labor Cost
        • 10.2.3 Manufacturing Process Analysis of Fibroblast Growth Factor Receptor 2
      • 10.3 Manufacturing Process Analysis of Fibroblast Growth Factor Receptor 2

      11 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 11.1 Fibroblast Growth Factor Receptor 2 Industrial Chain Analysis
      • 11.2 Upstream Raw Materials Sourcing
      • 11.3 Raw Materials Sources of Fibroblast Growth Factor Receptor 2 Major Manufacturers in 2017
      • 11.4 Downstream Buyers

      12 Marketing Strategy Analysis, Distributors/Traders

      • 12.1 Marketing Channel
        • 12.1.1 Direct Marketing
        • 12.1.2 Indirect Marketing
        • 12.1.3 Marketing Channel Development Trend
      • 12.2 Market Positioning
        • 12.2.1 Pricing Strategy
        • 12.2.2 Brand Strategy
        • 12.2.3 Target Client
      • 12.3 Distributors/Traders List

      13 Market Effect Factors Analysis

      • 13.1 Technology Progress/Risk
        • 13.1.1 Substitutes Threat
        • 13.1.2 Technology Progress in Related Industry
      • 13.2 Consumer Needs/Customer Preference Change
      • 13.3 Economic/Political Environmental Change

      14 Global Fibroblast Growth Factor Receptor 2 Market Forecast (2018-2025)

      • 14.1 Global Fibroblast Growth Factor Receptor 2 Sales Volume, Revenue and Price Forecast (2018-2025)
        • 14.1.1 Global Fibroblast Growth Factor Receptor 2 Sales Volume and Growth Rate Forecast (2018-2025)
        • 14.1.2 Global Fibroblast Growth Factor Receptor 2 Revenue and Growth Rate Forecast (2018-2025)
        • 14.1.3 Global Fibroblast Growth Factor Receptor 2 Price and Trend Forecast (2018-2025)
      • 14.2 Global Fibroblast Growth Factor Receptor 2 Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
        • 14.2.1 Global Fibroblast Growth Factor Receptor 2 Sales Volume and Growth Rate Forecast by Regions (2018-2025)
        • 14.2.2 Global Fibroblast Growth Factor Receptor 2 Revenue and Growth Rate Forecast by Regions (2018-2025)
        • 14.2.3 United States Fibroblast Growth Factor Receptor 2 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
        • 14.2.4 Europe Fibroblast Growth Factor Receptor 2 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
        • 14.2.5 China Fibroblast Growth Factor Receptor 2 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
        • 14.2.6 Japan Fibroblast Growth Factor Receptor 2 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
        • 14.2.7 Southeast Asia Fibroblast Growth Factor Receptor 2 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
        • 14.2.8 India Fibroblast Growth Factor Receptor 2 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
      • 14.3 Global Fibroblast Growth Factor Receptor 2 Sales Volume, Revenue and Price Forecast by Type (2018-2025)
        • 14.3.1 Global Fibroblast Growth Factor Receptor 2 Sales Forecast by Type (2018-2025)
        • 14.3.2 Global Fibroblast Growth Factor Receptor 2 Revenue Forecast by Type (2018-2025)
        • 14.3.3 Global Fibroblast Growth Factor Receptor 2 Price Forecast by Type (2018-2025)
      • 14.4 Global Fibroblast Growth Factor Receptor 2 Sales Volume Forecast by Application (2018-2025)

      15 Research Findings and Conclusion

        16 Appendix

        • 16.1 Methodology/Research Approach
          • 16.1.1 Research Programs/Design
          • 16.1.2 Market Size Estimation
          • 16.1.3 Market Breakdown and Data Triangulation
        • 16.2 Data Source
          • 16.2.1 Secondary Sources
          • 16.2.2 Primary Sources

        This report studies the global Fibroblast Growth Factor Receptor 2 market status and forecast, categorizes the global Fibroblast Growth Factor Receptor 2 market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

        The global Fibroblast Growth Factor Receptor 2 market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

        The major players covered in this report
        Advenchen Laboratories, LLC
        Amgen Inc.
        ArQule, Inc.
        Astellas Pharma Inc.
        AstraZeneca Plc
        AVEO Pharmaceuticals, Inc.
        Batu Biologics, Inc.
        Bayer AG
        Boehringer Ingelheim GmbH
        Bristol-Myers Squibb Company
        Celon Pharma Sp. z o.o.
        Debiopharm International SA
        Eddingpharm
        Eisai
        Eli Lilly and Company
        Hutchison MediPharma Limited
        Incyte Corporation
        Johnson & Johnson
        Les Laboratoires Servier SAS
        Nobelpharma Co., Ltd.
        Novartis AG
        Principia Biopharma Inc.
        Vichem Chemie Research Ltd.

        Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
        United States
        Europe
        China
        Japan
        Southeast Asia
        India

        We can also provide the customized separate regional or country-level reports, for the following regions:
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Argentina
        Rest of South America
        Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        ASP-5878
        AZD-4547
        BAY-1163877
        CPL-043
        Debio-1347
        EDP-317
        Others
        On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
        Clinic
        Hospital
        Others

        The study objectives of this report are:
        To analyze and study the global Fibroblast Growth Factor Receptor 2 sales, value, status (2013-2017) and forecast (2018-2025);
        To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
        Focuses on the key Fibroblast Growth Factor Receptor 2 players, to study the sales, value, market share and development plans in future.
        Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Fibroblast Growth Factor Receptor 2 are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025

        For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Key Stakeholders
        Fibroblast Growth Factor Receptor 2 Manufacturers
        Fibroblast Growth Factor Receptor 2 Distributors/Traders/Wholesalers
        Fibroblast Growth Factor Receptor 2 Subcomponent Manufacturers
        Industry Association
        Downstream Vendors

        Available Customizations
        With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
        Regional and country-level analysis of the Fibroblast Growth Factor Receptor 2 market, by end-use.
        Detailed analysis and profiles of additional market players.



        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $4,000.00
        $8,000.00
        2,916.00
        5,832.00
        3,408.00
        6,816.00
        441,880.00
        883,760.00
        295,000.00
        590,000.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report